#U.S. Hospital Emergency Department Market Analysis | Explore Tumblr posts and blogs

moontyger · 5 days ago

Text

Earlier this week, The New Yorker published a piece about a young woman killed by Texas’ abortion ban. Yeniifer Alvarez-Estrada Glick, the first reported post-Dobbs death, had diabetes, hypertension, and a history of pulmonary edema; she went to the emergency room with breathing problems just seven weeks into her pregnancy, and multiple times thereafter with ever-increasing issues. Yet even as Yeni got sicker and sicker, at no point did a doctor advise an abortion. No one even mentioned the possibility.

A big part of what makes abortion bans dangerous is the fear they instill in doctors and other medical professionals—it’s not just illegal to perform an abortion in Texas, but to ‘aid and abet’ one. As NPR reported last year, the law has doctors in the state “talking in code” about ending pregnancies. And one of the vital points made by New Yorker reporter Stephania Taladrid, is the way that bans impact “informed consent,” the principle that “doctors are ethically bound to give the patient enough information to grasp the possible costs and benefits of her choices.”

Yeni wasn’t given informed consent because of the abortion ban in Texas, but also because the hospital treating her was part of a Catholic health system—and religiously-affiliated hospitals don’t believe in abortion.

As I read the New Yorker investigation into Yeni’s death, I took note of the hospital system that failed her: Ascension. The name sounded familiar.

The very same day that Yeni’s story was shared with the world, National Nurses United (NNU) released a report showing how Ascension is fueling the U.S. maternal mortality crisis. In fact, NNU called Ascension, which has 140 hospitals in 19 states, “one of the nation’s worst offenders for closing obstetrics units.” From their report:

“Over the past decade, our analysis found that Ascension has eliminated obstetrics services at 16 hospitals, slashing approximately 26 percent of its labor and delivery departments it previously provided in 2012. Since 2022 alone, Ascension has shuttered five maternity wards, all in moderately-to-highly concentrated health care markets. …These cuts, predominantly in low-income neighborhoods that are disproportionately Black and Latine, are forcing pregnant patients to travel farther and endure longer wait times to receive care.”

Ascension, which claims to have a mission that pays “special attention to those who are poor and vulnerable,” reported a net income of over $5.7 billion in 2021, with a CEO who made more than $13 million that same year. They’re the second-largest and wealthiest Catholic health system in America.

In a moment when reproductive and maternal health care deserts are spreading, and maternal deaths are on the rise—especially among women of color, Black women, in particular—the report is incredibly damning. It tracks how Ascension has created maternal health deserts in multiple states, and how the health system’s bottom line trumps patient care.

Remember, right now nearly 2 million American women live in a “double desert”—a county without abortion access or maternal health care. And a report last year from the March of Dimes shows that nearly 6 million women live in counties with limited or no access to maternity care services. Those are deadly numbers.

The NNU’s study, for example, found that after Ascension closed an obstetrics unit in one of their Florida hospitals in 2019, the maternal death rate in the county more than doubled by 2021.

Their research also showed that Ascension closes down labor and delivery units in areas where the hospital system has market dominance—that means the company can cut staff and care without worrying about their revenue. Again, this is in spite of the fact that Ascension is a multi-billion dollar business.

This massive religious hospital system isn’t just putting people in danger through their obstetric services cuts—but cuts across the board. In 2022, The New York Times reported that “the heart of Ascension’s business strategy [is] cutting costs,” often at the expense of patient safety:

“At one point, executives boasted to their peers about how they had slashed $500 million from the chain’s labor costs. In the years before the pandemic, they routinely refused requests to hire more medical workers or fill open jobs, according to current and former hospital administrators and employees.”

The NYT investigation described patients at Ascension hospitals waiting for hours on gurneys despite needing urgent care, overworked staff, and nurses raising the alarm again and again only to be ignored. In one formal complaint, a nurse wrote, “Someone is going to die if this continues, and there is no indication that anyone is concerned.”

Someone did die: Yeniifer Alvarez-Estrada Glick. And like this nurse, I’m shocked at the lack of care in response to her story.

In the New Yorker, Taladrid reports that the hospital where Yeni sought care, Ascension Seton Edgar B. Davis, had shut down their labor and delivery unit years earlier. But with the closest OB ward thirty miles away, patients with urgent needs had nowhere else to go. Hospital staff told Taladrid that they were seeing more and more women giving birth, and that it felt like “uncontrolled chaos.”

This chaos, combined with a mandate from the hospital and the state to refuse to talk about abortion, is deadly. In a statement, NNU President Jean Ross slammed Ascension for ignoring their mission, saying, “Ascension’s creation of obstetric health care deserts increases the risk of dangerous complications and reduces opportunities for timely, lifesaving care for expecting parents and babies.”

I’ll be writing more about Ascension in the coming days, but I want to repeat something I’ve said often this week: We have to be loud and clear about what is causing post-Dobbs deaths. Stories around pregnancy and healthcare can be complicated, and still have a fundamental truth—that abortion bans kill.

The reality is that companies like Ascension are inextricably linked to abortion bans. They’re both part of the same system that prioritizes extremist religious ideology over women’s lives.

#health care #abortion rights #reproductive rights #Jessica Valenti #US politics #US legal system

4 notes · View notes

tamanna31 · 4 months ago

Text

Commercial Refrigeration Equipment Market Size, Share, Growth, Analysis Forecast to 2030

Commercial Refrigeration Equipment Market Size & Trends

The global commercial refrigeration equipment market size was valued at USD 40.82 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.2% from 2023 to 2030. The rapid expansion of the hospitality and tourism sector and the growing preference among end-consumers for takeaway meals are expected to drive market growth over the forecast period. In addition, increasing regulatory implications resulting in the adoption of lower global warming potential (GWP) commercial refrigerants coupled with ongoing technological breakthroughs will also provide growth prospects for the market.

A considerable rise in the international food trade has also boosted the demand for commercial refrigeration systems for frozen foods, processed foods, and seafood required for to storage and transportation. The continual innovations and rapid improvements in technologies, including liquid-vapor compression and ammonia absorption systems, are driving the product demand further. Various leading manufacturers are focusing on R&D activities to enhance the design and temperature control of their products to gain a competitive edge in the industry. The increasing need to control and monitor the environment of a commercial kitchen is expected to provide ample growth opportunities for the refrigeration industry over the forecast period.

Gather more insights about the market drivers, restrains and growth of the Commercial Refrigeration Equipment Market

Products equipped with automated or smart refrigeration controls are gaining massive traction in the market. As per the Federal Energy Management Program, commercial refrigerators with ENERGY STAR certification consume 1.89 kWh energy per day on an average, while refrigerators with lesser efficiency consume energy of around 4.44 kWh per day. The increasing demand for energy-efficient commercial refrigeration units driven by the rising awareness about their environment-friendly and cost-effective nature is encouraging the market players to develop innovative designs.

Climate concerns related to high GWP refrigerants, such as global warming and ozone depletion, are urging manufacturers to produce alternatives. The rising demand for technologies that can address hazardous gas emissions has urged market participants to equip their products with advanced magnetic refrigeration systems. These systems also improve the energy efficiency of refrigeration equipment, thereby minimizing operational costs. As per the U.S. Department of Energy statistics, these systems are highly energy-efficient and can help in energy saving of up to 30%.

The worldwide outbreak of the COVID-19 crisis led to the establishment of stringent containment measures, resulting in a temporary halt in the manufacturing and shipment of commercial refrigeration equipment. However, the pandemic created a strong demand for vaccine production and storage, which triggered the demand for cold storage solutions to support the mass immunization program against the coronavirus. The accelerating usage of vaccine storage units is likely to propel the demand for transportation refrigeration equipment in the subsequent years.

Browse through Grand View Research's Next Generation Technologies Industry Research Reports.

The global unmanned traffic management market size was estimated at USD 164.1 million in 2023 and is projected to grow at a CAGR of 34.0% from 2024 to 2030. The growing adoption of drones in various sectors, such as agriculture, logistics, and emergency services, has created a need for effective unmanned traffic management (UTM) systems, thereby driving market growth. The demand for UTM solutions to manage airspace safely and efficiently is growing as drones are increasingly used for commercial purposes.

The global border security market size was estimated at USD 26.76 billion in 2023 and is expected to grow at a CAGR of 6.8% from 2024 to 2030. The market growth is driven by the increasing geopolitical tensions, cross-border crimes, and the need for advanced surveillance systems. Governments worldwide are investing heavily in modernizing their border security infrastructure to enhance national security. The market encompasses a wide range of technologies, including unmanned aerial vehicles (UAVs), biometrics, radar systems, and advanced detection and tracking systems.

Commercial Refrigeration Equipment Market Segmentation

Grand View Research has segmented the global commercial refrigeration equipment market report based on the product, application, system type, refrigerant, capacity, distribution channel, and region

Commercial Refrigeration Equipment Product Outlook (Revenue, USD Million, 2018 - 2030)

Transportation Refrigeration Equipment

Trailers

Trucks

Shipping Containers

Refrigerators & Freezers

Walk-in-Refrigerators

Reach-in Refrigerators

Chest

Beverage Refrigeration

Display Showcases

Ice Cream Cabinets

Bakery/Deli Display

Others

Ice Merchandisers & Ice Vending Equipment

Other Equipment

Commercial Refrigeration Equipment System Type Outlook (Revenue, USD Million, 2018 - 2030)

Self-contained

Remotely Operated

Commercial Refrigeration Equipment Capacity Outlook (Revenue, USD Million, 2018 - 2030)

Less than 50 cu. Ft

50 to 100 cu. Ft

More than 100 cu. Ft

Commercial Refrigeration Equipment Application Outlook (Revenue, USD Million, 2018 - 2030)

Food Service

Food & Beverage Retail

Hypermarkets

Supermarkets

Convenience Store

Specialty Food Store

Others

Hotels and Hospitality

Pharmaceuticals

Healthcare

Biotechnology

Chemicals

Others

Commercial Refrigeration Equipment Refrigerant Outlook (Revenue, USD Million, 2018 - 2030)

Synthetic Refrigerants (HFCs, HCFCs)

Natural Refrigerants

Carbon Dioxide (CO2)

Ammonia (NH3)

Others

Commercial Refrigeration Equipment Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

OEMs (Original Equipment Manufacturers)

Distributors and Wholesalers

Retailers

Commercial Refrigeration Equipment Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

Canada

Europe

Germany

U.K.

France

Italy

Spain

Asia Pacific

Japan

China

India

South Korea

Australia

Latin America

Brazil

Mexico

Middle East and Africa (MEA)

Saudi Arabia

South Africa

Order a free sample PDF of the Commercial Refrigeration Equipment Market Intelligence Study, published by Grand View Research.

Key Companies profiled:

AHT Cooling Systems GmbH

Ali Group S.r.l. a Socio Unico

Carrier

Daikin Industries Ltd.

Dover Corporation

Electrolux AB

Hussmann Corporation

Illinois Tool Works Inc.

Johnson Control

Lennox International Inc.

Panasonic Corporation

Whirlpool Corporation

Recent Developments

In January 2024, Hussmann Corporation, a retail refrigeration systems company, launched Evolve Technologies, a new offering focused on the development of technologies that facilitate the use of environmentally friendly refrigerants.

In January 2022, Carrier Commercial Refrigeration installed its PowerCO2OL refrigeration system at a COVID-19 vaccine storage warehouse in Spain. This system uses carbon dioxide, a natural refrigerant, and serves as a sustainable and low global warming potential refrigerant to help preserve critical vaccines in Spain.

0 notes

shubhampawrainfinium · 5 months ago

Text

Bringing X-rays to the Patient: The Benefits of Portable Diagnostic Devices

The global portable X-ray devices market is on a significant growth trajectory, driven by advances in medical imaging technology and increasing demand for mobile diagnostic solutions. According to the report, the market is projected to grow at a compound annual growth rate (CAGR) of 11% over the forecast period of 2022-2028. The revenue generated by the portable X-ray devices market was approximately USD 6.3 billion in 2022 and is expected to reach approximately USD 12 billion by 2028.

What Are Portable X-ray Devices?

Portable X-ray devices are compact, mobile imaging systems designed to provide high-quality X-ray images in various settings outside traditional radiology departments. These devices are crucial for performing diagnostic imaging in emergency situations, remote locations, and in-home care settings. They offer the advantage of flexibility, allowing healthcare professionals to conduct imaging procedures without the need for patients to travel to a hospital or clinic.

Get Sample pages of Report: https://www.infiniumglobalresearch.com/reports/sample-request/327

Market Dynamics and Growth Drivers

Several factors are contributing to the robust growth of the global portable X-ray devices market:

Increasing Geriatric Population: The growing elderly population, who often have mobility issues and chronic conditions, is driving the demand for portable X-ray devices. These devices enable convenient and effective imaging for patients who are bedridden or have limited mobility.

Rising Incidence of Chronic Diseases: The prevalence of chronic diseases such as respiratory disorders, orthopedic conditions, and cardiovascular diseases is increasing, leading to a higher need for diagnostic imaging. Portable X-ray devices are essential for managing and monitoring these conditions.

Technological Advancements: Innovations in X-ray technology, including the development of lighter, more compact, and more efficient portable systems, are enhancing the capabilities and adoption of portable X-ray devices. Improvements in image quality, battery life, and ease of use are driving market growth.

Emergency and Critical Care Applications: Portable X-ray devices are increasingly used in emergency and critical care settings, where rapid and flexible diagnostic capabilities are crucial. Their ability to provide immediate imaging results supports timely medical decision-making.

Growing Demand for Home Healthcare: The rise in home healthcare services is fueling the need for portable diagnostic solutions. Portable X-ray devices facilitate imaging in home care environments, improving patient comfort and reducing hospital visits.

Regional Analysis

North America: The North American market leads in portable X-ray device adoption, supported by advanced healthcare infrastructure and high technological adoption. The U.S. and Canada are prominent markets due to their strong healthcare systems and increasing demand for mobile diagnostic solutions.

Europe: Europe is experiencing substantial growth in the portable X-ray devices market, driven by an aging population, rising healthcare expenditures, and technological advancements. Countries such as Germany, the U.K., and France are key contributors to market expansion.

Asia-Pacific: The Asia-Pacific region is witnessing rapid growth in the portable X-ray devices market, driven by increasing healthcare investments, expanding healthcare access, and rising prevalence of chronic diseases. Emerging economies like China and India are significant markets.

Latin America and Middle East & Africa: These regions are gradually adopting portable X-ray devices, influenced by improvements in healthcare infrastructure and growing healthcare needs. Market growth is supported by increasing investments in medical technology and healthcare services.

Competitive Landscape

The portable X-ray devices market is competitive, with several key players and emerging companies shaping the industry. Notable players include:

GE Healthcare: A leading manufacturer of portable X-ray devices known for its advanced imaging technology and comprehensive healthcare solutions.

Siemens Healthineers: Offers a range of portable X-ray systems with cutting-edge technology and high image quality.

Philips Healthcare: Provides innovative portable X-ray devices designed for various clinical applications, including emergency and critical care.

Canon Medical Systems: Known for its portable X-ray solutions that combine high performance with user-friendly features.

Carestream Health: Offers portable X-ray systems with advanced imaging capabilities and flexible options for diverse clinical settings.

Report Overview : https://www.infiniumglobalresearch.com/reports/global-portable-x-ray-devices-market

Challenges and Opportunities

The portable X-ray devices market faces challenges such as high costs associated with advanced technology and the need for regular maintenance and calibration. Additionally, there may be regulatory and compliance issues related to medical device standards.

However, there are significant opportunities for growth. Increasing healthcare investments, technological advancements, and rising demand for mobile and home healthcare solutions present avenues for market expansion. Companies that focus on innovation, cost reduction, and expanding their product offerings are well-positioned to capitalize on the growing demand for portable X-ray devices.

Conclusion

The global portable X-ray devices market is poised for substantial growth, driven by technological advancements, increasing demand for mobile diagnostics, and rising healthcare needs. With revenue expected to reach approximately USD 12 billion by 2028, the market presents significant opportunities for innovation and investment. As healthcare continues to evolve, portable X-ray devices will play a crucial role in enhancing diagnostic capabilities and improving patient care across various settings.

0 notes

industryinsightsandanalysis · 6 months ago

Text

Increasing Consumer Spending on Ready Made Food to Spur the Growth of the HoReCa Market, Globally

The growing demand for processed and packaged food in the region is one of the prominent reasons for the growth of the market. 80% of Americans’ total calorie consumption comes from store-bought foods and beverages (packaged and unpackaged). An emerging number of food processing companies in the United States leading to the growing market of food robots in the United States. More than 30% of the top 50 food & beverage-processing firms in the world. For instance, the average annual household food expenditure of the US population increased from USD 6,129 in the year 2010 to USD 8,169 in 2019. Whereas in 2018, the average U.S. household food expenditure amounted to approximately 7,923 U.S. dollars. Also, according to the statistics database Nation Master, In the U.S., the annual per capita spending on food is USD 2,678.

According to UnivDatos Market Insights (UMI)’ research report “Global HoReCa Market Analysis, 2021”, the Global HoReCa market is projected to grow at a CAGR of ~3% during 2021-27F. The key factors attributed to the growth of the HoReCa Market across the globe are growth in disposable income, the rising number of working women's and the rise in the tourism industry. The rise in the millennial working population with changing preferences to ready-to-eat foods and change in taste preferences coupled with the growing need for customized and newer food options has fueled the growth of the foodservice market. As per the U.S department of agriculture, the foodservice and food retailing industries supplied about US$1.79 trillion worth of food in 2019. In 2020, the food service and food retailing industries supplied about US$1.69 trillion worth of food.

Also, The growth of commercial spaces like café, restaurants as a place to socialize and spend time with different and innovative food consumption has altered food consumption habits As per the world bank, Adjusted net national income per capita (current US$) reached US$ 9,483.84 in 2019 from US$ 8,544.82 in 2015.

Based on the Service Type, the Hotels segment acquired the major market share and dominated the global HoReCa market in 2020. However, the demand for cafes and Restaurants is booming and is expected to gather a considerable market share by 2027. Proliferating number of schools, colleges, and booming hospitality and healthcare sector, globally is resulting in the growing demand for HoReCa. Also, a rise in the tourism sector is acting as a growth catalyst to the industry. As per The World Travel and Tourism Council (WTTC), the global contribution of 8.8 trillion USD to the global economy in 2018, represents 10.4% of the world’s total GDP

Based on the Category type, the HoReCa chain segment captured a major market share in 2020 and generated a considerable market share. The market of this segment is on the rise due to the growing demand from millennium for several purposes such as business meetings, parties, etc.

North America to Grab Lion’s Share, But the Asia Pacific to witness Explicit Growth

Based on the Region, the North American region dominated the global HoReCa market in 2020. The region grabbed considerable market share from the global market. Moreover, the region is projected to maintain its dominance during the forecasted period 2021-27, stated in UnivDatos Market Insights (UMI)’ research report “Global HoReCa Market Analysis, 2021”.

According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the global HoReCa market are Hilton Worldwide Holdings Inc., Hyatt Hotels Corporation, Marriott International, Inc., InterContinental Hotels Group plc, Wyndham Hotel Group, LLC, McDonald's Corporation, Yum! Brands, Inc., Restaurant Brands International Inc., Inspire Brands, Inc, The Coca-Cola Company (Costa Coffee), etc., The players are focused on launching new products for gaining customers' traction and expanding their geographical reach to get a competitive edge in the industry.

“Global HoReCa Market Analysis, 2021” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for the HoReCa market across the Globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitors' capabilities on 16 parameters. This will help companies in the formulation of Go to Market Strategies and identifying the blue ocean for its offerings.

Request Free Sample Pages with Graphs and Figures Here https://univdatos.com/get-a-free-sample-form-php/?product_id=11489

Market Segmentation:

By Service Type (Hotels, Restaurants, Cafés & Pubs)

By Category Type (Single Outlet, HoReCa Chain)

By Region (North America, Europe, Asia-Pacific, Rest of the World)

By Company (Hilton Worldwide Holdings Inc., Hyatt Hotels Corporation, Marriott International, Inc., InterContinental Hotels Group plc, Wyndham Hotel Group, LLC, McDonald's Corporation, Yum! Brands, Inc., Restaurant Brands International Inc., Inspire Brands, Inc, The Coca-Cola Company (Costa Coffee)

Key questions answered in the study:

What are the current and future trends of the Global HoReCa industry?

How the industry has been evolving in terms of end-user demand and application areas?

How the competition has been shaping across the countries followed by their comparative factorial indexing?

What are the key growth drivers and challenges for the HoReCa industry?

What are the customer orientation, purchase behavior, and expectations from the HoReCa firms across various regions?

UnivDatos Market Insights

Email - [email protected]

Contact Number - +1 9782263411

Website -www.univdatos.com

#HoReCa Market

0 notes

industryforecastnews · 9 months ago

Text

Trauma Care Centers Market Size To Reach USD 26.9Bn By 2030

Trauma Care Centers Market Growth & Trends

The global trauma care centers market size is expected to reach USD 26.9 billion by 2030, according to a new report by Grand View Research. It is expected to expand at a CAGR of 7.53% from 2023 to 2030. The market is expected to be driven by the factors such as the rising number of trauma cases and the growing utilization of trauma care services among the pediatric and geriatric population. Additionally, the growing number of trauma care centers globally is expected to boost the growth of the market during the forecast period.

Growing incidence of injuries and falls and increasing demand for trauma care have led to a gradual increase in the number of standalone and hospital-owned trauma care centers. Many established hospitals are having dedicated trauma care departments to provide emergency medicine to people injured due to burns, road traffic accidents, and other injuries.

Furthermore, the COVID-19 pandemic has adversely affected the market growth owing to the delay in elective procedures, postponement in non-urgent treatments in hospitals, reduction in outpatient visits, and unnecessary emergency department visits. According to an article published in BMC, the initial stages of the pandemic were associated with a 32.5% decline in trauma patient volumes and different injury patterns at 85 trauma centers in a multiple states system.

Request a free sample copy: https://www.grandviewresearch.com/industry-analysis/trauma-care-centers-market

Trauma Care Centers Market Report Highlights

On the basis of facility type, the in-house segment dominated the market in 2021 in terms of revenue. This can be attributed to the presence of specialized in-house trauma care in acute care hospitals

By trauma type, the falls segment held the largest revenue share in 2021 owing to the rise in the prevalence of severe to moderate injuries caused due to falls

Based on service type, outpatient services held the largest share in terms of revenue in 2022 due to better access to care and better reimbursements

North America held the largest share in terms of revenue in 2022 owing to the presence of high-quality and well-established trauma care centers and rising cases of road accidents and sport-related injuries

India and China, the two emerging economies in the Asia Pacific region, have observed rapid economic expansion and an increase in healthcare spending. The need for sophisticated trauma treatment is anticipated to grow in these countries in the coming years as a result of rising disposable income

The companies operating in the market are seeking accreditations from the authorities to stay competitive in the market. For instance, in September 2019, NYC Health + Hospitals/Bellevue received provisional status to operate as a Level II Trauma Center for Pediatrics. The emergency trauma room serves children aged 15 and below

Trauma Care Centers Market Segmentation

Grand View Research has segmented the global trauma care centers market based on facility type, trauma type, service type, and region:

Trauma Care Centers Facility Type Outlook (Revenue, USD Million, 2017 - 2030)

In-house

Standalone

Trauma Care Centers Trauma Type Outlook (Revenue, USD Million, 2017 - 2030)

Falls

Traffic-related Injuries

Stab/Wound/Cut

Burn Injury

Brain Injury

Other Injuries

Trauma Care Centers Service Type Outlook (Revenue, USD Million, 2017 - 2030)

Inpatient

Outpatient

Rehabilitation

Trauma Care Centers Regional Outlook (Revenue, USD Million, 2017 - 2030)

North America

U.S.

Canada

Europe

Germany

U.K.

France

Italy

Spain

Asia Pacific

Japan

China

India

Australia

South Korea

Latin America

Brazil

Mexico

Argentina

Middle East & Africa (MEA)

South Africa

Saudi Arabia

UAE

List of Key Players of the Trauma Care Centers Market

University of Alabama Hospital

Banner University Medical Center Phoenix

St. Joseph’s Hospital and Medical Center

Albany Medical Center

Ascension St. John Hospital

Bellevue Hospital Center

China Medical University Hospital

Klinikum Stuttgart

Kaiser Permanente

University Hospital Southampton NHS Foundation Trust

Request a free sample copy:https://www.grandviewresearch.com/industry-analysis/trauma-care-centers-market

#Trauma Care Centers Market #Trauma Care Centers Market Size #Trauma Care Centers Market Forecast #Trauma Care Centers Market Trends

0 notes

cmipooja · 1 year ago

Text

Global U.S. Hospital Emergency Department Market Is Estimated To Witness High Growth Owing To Increasing Demand for Critical Care Services

The global U.S. Hospital Emergency Department market is estimated to be valued at US$ 158.2 Bn in 2022 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The U.S. Hospital Emergency Department market refers to the healthcare facilities that provide immediate medical attention and critical care services to patients suffering from injuries or serious illnesses. These departments play a vital role in saving lives by offering timely emergency care. The key advantage of hospital emergency departments is their ability to provide specialized medical care, such as trauma care, cardiac care, and pediatric care, which is crucial in critical situations. The increasing demand for quality emergency care services and the need for timely access to healthcare facilities are driving the growth of the U.S. Hospital Emergency Department market. Market Key Trends: One key trend in the U.S. Hospital Emergency Department market is the adoption of telemedicine and telehealth technologies. Telemedicine allows healthcare professionals to remotely diagnose and treat patients, which is especially beneficial in emergency situations where immediate medical attention is required. It enables patients to receive timely medical advice and assistance from healthcare experts without physically visiting a hospital emergency department. For example, in rural areas where access to healthcare facilities is limited, telemedicine can help bridge the gap by connecting patients with emergency care providers through video consultations. PEST Analysis: Political: The political landscape greatly influences the U.S. Hospital Emergency Department market. Healthcare policies, regulations, and funding initiatives implemented by governments can impact the accessibility, quality, and cost of emergency care services. Economic: Economic factors such as the GDP, disposable income, and healthcare expenditure of a region determine the affordability and demand for emergency care services. The economic growth and stability of a country play a significant role in the development of the U.S. Hospital Emergency Department market. Social: Social factors like population demographics, lifestyle changes, and the prevalence of chronic diseases affect the demand for emergency care services. An aging population and an increase in chronic illnesses contribute to the rising need for critical care services. Technological: Technological advancements have revolutionized the U.S. Hospital Emergency Department market. Innovations in medical devices, telehealth technologies, electronic health records, and data analytics have enhanced the efficiency, accuracy, and quality of emergency care services. Key Takeaways: 1. Market Size: The U.S. Hospital Emergency Department Market Size is expected to witness high growth, exhibiting a CAGR of 5.5% over the forecast period. The increasing demand for critical care services and the need for timely access to emergency care drive this growth. 2. Regional Analysis: North America is expected to dominate the U.S. Hospital Emergency Department market due to its well-developed healthcare infrastructure, high healthcare expenditure, and government initiatives to improve emergency care services. However, Asia Pacific is anticipated to be the fastest-growing region, driven by the increasing population, rise in chronic diseases, and growing investments in healthcare infrastructure. 3. Key Players: Key players operating in the global U.S. Hospital Emergency Department market include Parkland Health & Hospital System, ST. Joseph's Health, Natchitoches Regional Medical Center, Montefiore Medical Center, Lakeland Regional Health, USA Health, and Schoolcraft Memorial Hospital, among others. These players focus on expanding their service offerings, adopting advanced technologies, and collaborating with other healthcare providers to enhance their market presence.

0 notes

rohans18 · 1 year ago

Text

Cerebral Vasospasm Market CAGR, Trends, Top Players, Analysis, Industry Size - Forecast 2028

Global Cerebral Vasospasm Market, By Diagnosis (CT Scan, Computed Tomography Angiography (CTA), Digital Subtraction Angiography (DSA), Magnetic Resonance Angiography (MRA) and Transcranial Doppler (TCD)), Treatment (Nimodipine, Triple-H Therapy, Balloon Angioplasty, Vasopressors, Inotropes, Thrombolytic Agents and Anti-inflammatory Agents), End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Trauma Centers, Emergency Departments, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028

In the consistent Cerebral Vasospasm market research report, industry trends are put together on macro level with which clients can figure out market landscape and possible future issues about Cerebral Vasospasm industry. The scope of this market report include but is not limited to latest trends, market segmentation, new market entry, industry forecasting, future directions, opportunity identification, strategic analysis and planning, target market analysis, insights and innovation. The report presents with the CAGR value fluctuations for the specific forecasted period which helps decide costing and investment strategies. An influential Cerebral Vasospasm market report brings precise and exact market research information that drives business into the right direction.

Key Players

The major players covered in the Cerebral Vasospasm market report are ABELDent Inc., Dentimax, Carestream Health, Henry Schein One, YAPI Inc., ACE Dental, Datacon Dental Systems, KaVo Dental, SMK Imaging, Open Cerebral Vasospasm, PLANMECA OY, Dentsply Sirona, Consult-PRO, Patterson Companies Inc., NF Dental Group, Curve Dental, LLC, PRACTICE-WEB INC., NXGN Management, LLC, BestoSys Solutions Private Limited and Allscripts Healthcare, LLC among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Browse More Info @ https://www.databridgemarketresearch.com/reports/global-cerebral-vasospasm-market

The research studies entailed in the winning Cerebral Vasospasm market report supports to estimate several important aspects that includes but are not limited to investment in a rising market, success of a new product, and expansion of market share. The strategies underlined here mainly consist of new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others that boost footprints in this market. Several other factors such as import, export, gross margin, price, cost, and consumption are also analyzed under the section of production, supply, sales and market status.

Key questions answered in the report:

Which product segment will grab a lion’s share?

Which regional market will emerge as a frontrunner in coming years?

Which application segment will grow at a robust rate?

Report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Cerebral Vasospasm Market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Table Of Content

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Global Market

Part 04: Global Market Size

Part 05: Global Market Segmentation By Product

Part 06: Five Forces Analysis

More Reports:

Diuretic Drugs Market

Patient Engagement Technology Market

Healthcare Business Intelligence Market

Chinese Hamster Ovary cells (CHO) Market

Anti-cancer Drug Market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

0 notes

healthcaremarketfmi · 2 years ago

Text

Liquid Biopsy Market In-Depth Analysis with Booming Trends Supporting Growth and Forecast 2032

The global liquid biopsy market is anticipated to create lucrative growth opportunities over the projection period by exhibiting a total CAGR of 13.49% from 2022 to 2032. The global market is expected to be valued at US$ 1,146 Million in 2022 and surpass a valuation of around US$ 4,126 Million in 2032. The growth of the liquid biopsy market is attributed to increasing cancer incidences and low treatment rates.

A liquid biopsy is known to be a non-invasive procedure as compared to surgical biopsies which aid in discovering a tumor with the help of a simple blood sample. Traces of cancer’s DNA in the blood can help in giving clues about which treatments are most likely to work for that patient. Liquid biopsies are commonly used to diagnose non-small cell lung cancer (NSCLC) and screening or a companion diagnostic for numerous other types of cancers such as gastrointestinal, colorectal, breast, prostate, and ovarian cancer.

The Cost-effectiveness and high efficacy of liquid biopsy over several other diagnostic tests are chief factors responsible for market growth. Fast-track approvals from regulatory bodies such as the U.S. Food and Drug Administration (FDA) for non-invasive cancer diagnosis tests will continue creating growth opportunities.

Get Sample Report + Related Graphs & Charts @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1396

Key Takeaways

For decades, cancer has been constantly affecting humanity and the numbers continue to surge even with the emergence of better treatment and care. According to the reports by the World Health Organization (WHO), In 2020 it reported around 10 million deaths caused due to cancer. This staggering rise in number emphasizes the need for accurate and convenient cancer diagnostic systems for early detection.

Governments in several high cancer-burden nations have made a pledge to assist cancer research by offering them adequate funds that can aid in improved outcomes. For instance, as per the National Institute of Health (NIH), the federal government has allocated US$ 119 Mn to National Cancer Institute for the fiscal year 2021.

The India-UK Cancer Research Initiative in 2018, focused on improved and affordable approaches to cancer diagnosis and treatment. This initiative received investments valued at £5 Mn from the Department of Biotechnology (DBT), Ministry of Science & Technology, India, and Cancer Research UK (CRUK) each over a 5-year program.

The government-led initiatives are expected to further promote cancer specialists all over the world in order to set research goals aimed at affordability, convenience, and optimal patient care in cancer treatments. Adequate funding will allow experts to develop research alliances to enable significant improvements against numerous cancer outcomes.

Competitive Landscape

Key players in the liquid biopsy market are focusing on strategic collaborations with several end-users including hospitals, diagnostic centers, and cancer research institutes to strengthen their product offerings in the market. As per FMI analysis, tier-1 players will account for approximately 20-25% of the total sales.

Prominent industrial research funding along with product development agreements will offer proprietary benefits to manufacturers, helping them contribute to the development of accurate diagnosis methods for various cancers. In addition, gaining patents and government approvals for new technologies will remain one of the prominent growth strategies.

For more Report Customization, connect with us at https://www.futuremarketinsights.com/customization-available/rep-gb-1396

More Insights into the Liquid Biopsy Market

According to the FMI analysis, the U.S. is anticipated to account for around 51% of the total market share in the global liquid biopsy market during the projection period. Growth prospects in the U.S. are attributed to surging government funding in order to support cancer research. The rising prevalence of cancer across the U.S. will generate high demand for highly accurate liquid biopsy services. Widespread technological developments including artificial intelligence, machine learning, and microchip-based liquid biopsy diagnostic services will lead to market expansion in the U.S.

The European liquid biopsy market is anticipated to surge significantly throughout the forecast period, attributed to the desirable healthcare policies along with high average per capita healthcare costs, which have produced a favorable climate in the United Kingdom for the adoption of modern cancer diagnostic technology.

The technological developments in the U.K. are expected to offer lucrative growth opportunities for players operating in the market, allowing them to benefit from technological advancements for better products and services. The U.K. will account for 24% of the market share, as estimated by FMI.

According to the FMI market survey, government initiatives in emerging economies like India are aimed at improving cancer awareness, research, and development and are anticipated to propel the growth of the liquid biopsy market in India, as per FMI’s market survey. As revealed by the National Cancer Registry, cancer incidence in men is estimated to reach 736,575 in 2025, with 806,218 cases to be recorded in women.

Grow your profit margin with Future Market Insights – Buy the report@ https://www.futuremarketinsights.com/checkout/1396

Key Segments Profiled in the Liquid Biopsy Industry Survey

Liquid Biopsy Market by Marker Type:

CTCs (Circulating Tumour Cells)

ctNA (Circulating tumor Nucleic Acids)

Exosomes

Liquid Biopsy Market by Sample Type:

Blood Liquid Biopsy

Urine Liquid Biopsy

Others (Plasma, Saliva, CSF) Liquid Biopsy

Liquid Biopsy Market by Application Type:

Liquid Biopsy for Lung Cancer

Liquid Biopsy for Gastrointestinal Cancer

Liquid Biopsy for Prostate Cancer

Liquid Biopsy for Breast Cancer

Liquid Biopsy for Colorectal Cancer

Liquid Biopsy for Leukemia

Liquid Biopsy Market by Region:

North America Liquid Biopsy Market

Latin America Liquid Biopsy Market

Western Europe Liquid Biopsy Market

Eastern Europe Liquid Biopsy Market

APEJ Liquid Biopsy Market

Japan Liquid Biopsy Market

Middle East and Africa Liquid Biopsy Market

0 notes

impossibledeanmakerwombat · 2 years ago

Text

Liquid Biopsy Market to Latest Research, Industry Analysis, Driver, Trends, Business Overview, Key Value,Demand And Forecast 2022 to 2032

The global Liquid Biopsy Market is anticipated to create lucrative growth opportunities over the projection period by exhibiting a total CAGR of 13.49% from 2022 to 2032. The global market is expected to be valued at US$ 1,146 Million in 2022 and surpass a valuation of around US$ 4,126 Million in 2032. The growth of the liquid biopsy market is attributed to increasing cancer incidences and low treatment rates.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1396

Key Takeaways

Ask An Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-1396

Competitive Landscape

More Insights into the Liquid Biopsy Market

Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-1396

Key Companies Profiled

BIOCEPT, INC.

Qiagen N.V.

Trovagene, Inc

Janssen Global Services, LLC

MDxHealth SA

Natera, Inc

Hoffmann-La Roche Ltd

Silicon Biosystems

Pathway Genomics Corporation

Sysmex Corporation

Key Segments Profiled in the Liquid Biopsy Industry Survey

Liquid Biopsy Market by Marker Type:

CTCs (Circulating Tumour Cells)

ctNA (Circulating tumor Nucleic Acids)

Exosomes

Liquid Biopsy Market by Sample Type:

Blood Liquid Biopsy

Urine Liquid Biopsy

Others (Plasma, Saliva, CSF) Liquid Biopsy

Liquid Biopsy Market by Application Type:

Liquid Biopsy for Lung Cancer

Liquid Biopsy for Gastrointestinal Cancer

Liquid Biopsy for Prostate Cancer

Liquid Biopsy for Breast Cancer

Liquid Biopsy for Colorectal Cancer

Liquid Biopsy for Leukemia

1 note · View note

market-insider · 2 years ago

Text

Latest Developments & COVID-19 Impacts Analysis On U.S. Hospital Emergency Department Market, 2022

The U.S. hospital emergency department market size is expected to reach USD 246.3 billion by 2030, registering a CAGR of 5.7%, according to a new report by Grand View Research, Inc. Rising prevalence of diseases requiring immediate care such as cardiac arrest is expected to drive the growth of this market. Hospital Emergency Departments (EDs) are preferred by such individuals in need of emergency care due to the 24-hour availability of care over other medical centers. There has been an increase in the number of patients with acute psychiatric crises visiting hospital EDsin the last few years.

According to National Hospital Ambulatory Medical Care Survey, in 2018, there were around 1.15 million ED visits due to problems related to psychological and mental disorders. Furthermore, a total of 2.4 million ED visits occurred due to diseases of the nervous system. Neurologic emergencies include conditions such as stroke, migraine, Alzheimer's disease, and others. Stroke is a major contributor to ED visits, with around 795,000 individuals suffering a stroke annually. This is likely to increase the number of ER visits in the coming years.

Gain deeper insights on the market and receive your free copy with TOC now @: U.S. Hospital Emergency Department Market Report

To meet the high demand for EDs and create awareness, hospitals are adopting new technologies and conducting various business activities. For instance, in May 2019, Montefiore Medical Center installed communication systems in the emergency room, which facilitates prehospital communication between ED staff and first responders. Similarly, in July 2019, Clarion Hospital collaborated with Allegheny Health Network to bring Advanced Telestroke Services to its ED to treat patients suffering from stroke symptoms.

Moreover, there is a trend of adopting new treatment options, such as Artificial Intelligence (AI), and telehealth for emergency care of acute illnesses and injuries. For instance, in October 2020, Northwestern Memorial Hospital partnered with Caption Health to acquire Caption AI, the AI technology for ultrasound, for use in EDs. Such measures are expected to increase demand for emergency care due to growing awareness about the availability of accurate and quick treatment options and increasing adoption of new technologies. The onset of the COVID-19 pandemic resulted in revenue loss for emergency departments in the United States, due to the substantial reductions in the number of ED visits. The decline in visits was largely due to people delaying treatment to avoid infection, a decrease in surgery volume, and social distancing restrictions. According to a study from researchers at Yale and the Mayo Clinic, ED visits declined by 41.5% (in Colorado) to 63.5% (in New York) in the year after the pandemic outbreak.

#U.S. Hospital Emergency Department Market Size #U.S. Hospital Emergency Department Market Share #U.S. Hospital Emergency Department Market Latest Trends #COVID-19 Impacts Analysis

0 notes

researchinhealthcare · 3 years ago

Text

POC Blood Gas and Electrolyte Devices Market to Touch till 2023 | Global Industry Analysis

POC Blood Gas and Electrolyte Devices Market Highlights :

Point of care blood gas and electrolyte analyzers is the new technology, which helps in reducing therapeutic turnaround time, enhancing patient satisfaction, accuracy, and help to improve hospital operations. Rising prevalence of chronic diseases and cancer across the globe, increasing the treatment of NICUs, ICUs, Cardiovascular Operating Room (CVOR), and emergency department, which drives the global point of care blood gas and electrolyte devices market growth.

In 2017, due to changes in the regulatory policies of the U.S., R&D investment is affected to some extent. In 2016, R&D spending of the US was 527.5 billion, which grew by 1.6% in 2017. Currently, the major shares of the global market are dominated by few leading players, and they can fluctuate the costs of the products. In developing regions such as Asia Pacific the suppliers are trying to provide their products at affordable price.

The global point of care blood gas and electrolyte devices market is expected to grow at a CAGR of 7.8% during the forecast period 2017-2023.

POC Blood Gas and Electrolyte Devices Market Segmentation :

The global point of care blood gas and electrolyte gas devices market has been segmented on the basis of types and end users.

On the basis of the types, the market is segmented into consumables and Instruments. The instrument type is sub-segmented into benchtop and portable devices. The consumable devices are further segmented into reagents, cartridges, and others.

On the basis of the end users, the market is segmented into hospitals & clinics, home care, research institutions, and others.

Free Sample Report Click @ https://www.marketresearchfuture.com/sample_request/5085

POC Blood Gas and Electrolyte Devices Market Regional Analysis :

The Americas dominate the global market owing to a huge population with chronic diseases such as diabetes, kidney, and liver disease, increasing government support for research & development, and high health care expenditure. According to the WHO, in 2014, 9.7% of the total America population is having diabetes. Thus, increasing prevalence of diabetes has boosted the market growth. Additionally, changing lifestyle and the presence of major players in the market have fuelled the growth of the market.

Europe is the second largest point of care devices market across the globe, which is followed by Asia Pacific. Asia Pacific is the fastest growing market and majorly driven by India and China owing to a huge number patients with chronic diseases and rapidly growing economy.

According to the WHO, 60% of the global diabetic population lives in Asia Pacific region. The healthcare expenditure of Asia Pacific has increased over the last few years, which has contributed to the growth of the market.

The Middle East and Africa region account for the least share of the global market. Whereas, Africa holds the least share of the global market due to limited availability of medical facilities and poor economic condition of the region.

POC Blood Gas and Electrolyte Devices Market Key Players :

Some of the major players in this market: Siemens, Abbott, F. Hoffman-La Roche Ltd., Radiometer, Nova medical, Edan Instruments Inc., and Instrumentation Laboratory

Access Report Details @ https://www.marketresearchfuture.com/reports/poc-blood-gas-and-electrolyte-market-5085

#POC Blood Gas and Electrolyte Devices Market Size #POC Blood Gas and Electrolyte Devices Market Growth

1 note · View note

theculturedmarxist · 4 years ago

Link

Yves here. One of the big sources of the lack of democratic influence on policy is the way so many elements of fiscal decisions are hostage to economists’ beliefs, many of which are at best outdated, just plain wrong, or shamelessly abused (one example of abuse comes below). The presumption that economists know better shuts off many key decisions from debate.

Nathan Tankus below explains the role of fiscal multipliers, which in lay-speak is “how many dollars of GDP growth does a dollar of fiscal spending generate?” Austerians bizarrely believe in “fiscal consolidation” as in that budget-cutting will improve debt to GDP ratios. The problem with that view is that reducing expenditures results in economic contraction that is even larger than the cut in spending, making debt to GDP ratios worse. Greece was the poster child of this phenomenon. The IMF had nevertheless made this approach the centerpiece of its “programs” which had the appearance of working, because they would usually be imposed on countries in the midst of a currency crisis. Dropping foreign exchange rates in conjunction with imposing the austerity hair shirt would (sometimes but not always) provide enough of a trade boost to offset the fiscal downdraft.

Needless to say, the blind application of “fiscal consolidation” didn’t work in the Eurozone, where member states were all on the Euro and thus could not lower their exchange rates. The IMF admitted as much, when its then chief economist Olivier Blanchard announced that the IMF had determined that at least in weak economies, “fiscal multipliers are greater than one”. Even though that was tantamount to saying its playbook was wrong, the organization continues to dole out the same bad medicine.

By Nathan Tankus. Originally published at Notes on the Crises

Since the CARES act passed in late March, there have not been any more major fiscal packages passed through congress until this week. I’ll be writing about this second fiscal package in more detail later this week.

Since no substantial policy changes have been in the works until quite recently, the more abstract questions about fiscal policy — how effective it is, how you decide how big fiscal packages should be — has been pushed into the background for most of the 2020 crisis.

Meanwhile, because of promising vaccine news (as well as a deep desire to avoid the present), financial market journalists, participants and scholars are jumping ahead to an optimistically predicted “boom” in the summer of 2021. I think these discussions are very premature.

In short, it’s become clear from a number of different angles that the notion that fiscal support to the U.S. economy remains wildly inadequate will become more controversial in 2021. As this package starts impacting the economy and the prospects of a true reopening driven by a vaccine starts to seem like more of a reality (even if it ends up being a mirage), the discourse about austerity and worries about inflation will become louder. No one doubted how deep the crisis was in December 2008 but passing a large fiscal package became much more controversial in 2009. Political and intellectual winds can shift fast. In this context I want to step back a bit, and cover some more basic and abstract points. In this “lameduck” period before the next inauguration, we have some time to make fiscal policy somewhat more understandable. But we need to watch out for missteps in the fiscal policy conversation that happen in Biden’s critical first 100 days.

https://twitter.com/BharatRamamurti/status/1306713487306035202

The most critical concept that gets utilized in modern public policy conversations about fiscal policy is the “fiscal multiplier”. In the video above, you can see Bharat Ramamurti of the CARES Act Congressional Oversight Commission embarrass a right wing witness over his misrepresentation of other people’s research. In the clip, what they are essentially fighting over is how “large” or “small” fiscal multipliers are — for both state and local government relief. And yet, what the fiscal multiplier fundamentally is does not get explained. Nor is the importance of “large” and “small” multipliers spelled out. Why should we care what the size of this “multiplier” is.

The fiscal multiplier is one of the most famous ideas that appeared in John Maynard Keynes seminal book The General Theory of Employment, Interest and Money — perhaps the most famous single idea to make it to modern thinking. The modern form of a fiscal multiplier as used in public policy is defined by the Congressional Budget Office. In their formulation, there are two important fiscal multipliers. One they call the “demand multiplier” and the other they call the “output multiplier”. The demand multiplier is multiplied by the “direct effects” on demand to tell us how much total income across the economy (The “gross domestic product”) responds to additional spending. So, for example, if the government paid to build a hospital then the “direct effects” would be the total amount of money spent on the wages, inputs and other currently produced goods and services needed to build the hospital.

The “demand multiplier” is thus all the secondary increases in spending (and thus income) that emerge because of that “direct” increase in demand. This can be hard for people to wrap their heads around but it may be easier to grasp when you realize that everyone’s spending is someone else’s income. When your boss pays you, he’s making an expenditure. When you pay someone else, you’re making an expenditure. To that person, what you are paying them is their income. This web of payment relationsmean that when spending increases- either because a company builds a factory or a government pays for vaccine distribution, incomes increase. Meanwhile people with higher incomes generally spend more, even if they don’t spend their whole increase in income. This is fundamentally where this secondary or “multiplier” effect comes from. We will of course return to this concept multiple times later in the series.

[image missing due to .webp shit]

If one knows the direct effect of a particular spending project on demand plus the demand multiplier then you can calculate how much total income will increase. Yet the equation above combines the “direct effects on demand” and the “demand multiplier” into what it calls the “output multiplier”. Why does it do that? In order to multiply this “output multiplier” by the “budgetary cost of a change in fiscal policy”. This is important for policymakers who want to increase overall demand for as few dollars as possible. If you think that the limits on fiscal policy are some metrics for how much you can safely “borrow” rather than spending’s effect on employment, inflation or the trade deficit, then it is important that you don’t “waste” your budget on things that don’t increase demand by substantial amounts for each dollar appropriated. Thus if the output multiplier is small a policy will not be worth it to the budget conscious even if the demand multiplier is large- or predictable. This is why it’s so important to Bharat Ramamurti in the above clip to establish that fiscal multipliers for state and local government aid in this crisis are larger than the witness was claiming. The smaller the multiplier, the more unappealing it seems to policymakers. This is a point that we will return to later in the series.This inclusion of what the CBO calls a “budgetary cost of a change in fiscal policy” leads to significant issues in public policy analysis because it is ambiguous what the relevant “change in fiscal policy” is. For example, if congress appropriates 10 billion dollars for the construction of additional public schools should that total amount be considered the “budgetary cost” even if it is not expected that that 10 billion dollars will be doled out by the department of education in that single year? There is a danger of making policies look worse than they actually are by comparing what is effectively a multi-year budget to a yearly effect on demand. In a future part of this series we will examine this critical point when it comes to thinking about the government’s role as creditor and policies- such as student debt cancellation- where output multipliers can vary by extremes depending on what methodology you choose.

I know that that was a lot to absorb from one piece and don’t feel dismayed if you feel that you are missing important elements of what’s been discussed. We will be going over important points multiple times. Part Two in this series will be coming next week since there’s a number of things about the current Covid Relief package that I will need to cover in the next few days… including apparently Trump’s potential veto??

Try to enjoy your holidays with everything going on and please stay safe.

#economics #economy #economic theory #austrian economics #nathan tankus #bharat ramamurti #economic policy

11 notes · View notes

tamanna31 · 6 months ago

Text

Industry Outlook of Blood Gas And Electrolyte Analyzer Market 2024 Trends to 2030

Blood Gas And Electrolyte Analyzer Industry Overview

The global blood gas and electrolyte analyzer market size was estimated at USD 2.76 billion in 2023 and is projected to grow at a CAGR of 4.5% from 2024 to 2030. The market's growth is attributed to the growing prevalence of chronic diseases, rising geriatric population, and increasing regulatory support and funding for developing novel blood gas and electrolyte analyzers. Chronic diseases such as diabetes, cardiovascular diseases, and chronic respiratory conditions are becoming common due to various factors, including lifestyle changes and urbanization. These conditions require continuous monitoring and management.

Chronic diseases lead to complications that require blood gas and electrolyte analysis. For instance, diabetes can lead to diabetic ketoacidosis, a condition that necessitates the monitoring of blood pH and electrolyte levels. Similarly, cardiovascular diseases can result in heart failure, demanding regular checks of blood oxygen levels and electrolyte balance. As the prevalence of these diseases rises, the demand for blood gas and electrolyte analyzers is growing.

The growing geriatric population worldwide significantly drives the market. Aging leads to an increase in age-related diseases and conditions that require close monitoring & management. These conditions necessitate blood gas and electrolyte analyzers, which measure various parameters such as pH, gases (oxygen & carbon dioxide), and electrolytes in the blood. This equipment is crucial in diagnosing and monitoring patients in critical care, respiratory care, and for those undergoing surgery. According to the Population Reference Bureau, the number of individuals in the U.S. aged 65 years and above is projected to increase from 58 million in 2022 to 82 million by 2050. This rising aging population is anticipated to bring about challenges and opportunities in the country with the rising adoption of blood gas and electrolyte analyzers.

Gather more insights about the market drivers, restrains and growth of the Blood Gas And Electrolyte Analyzer Market

Regulatory support and funding are crucial factors driving the market. These analyzers are essential for critical care, emergency departments, and clinical laboratories, providing vital information about patients' respiratory & metabolic status. Governments across various regions have been focusing on improving healthcare infrastructure and quality. Regulatory bodies have implemented stringent guidelines and standards for medical devices, ensuring the reliability, accuracy, and safety of blood gas & electrolyte analyzers. This regulatory environment helps build trust among healthcare providers and patients, promoting the adoption of these devices.

Furthermore, with the expansion of healthcare facilities, mainly in rural and remote areas, there is a growing demand for advanced medical equipment. New hospitals and clinics need the latest diagnostic technologies to provide high-quality care, driving the market demand. Regulatory bodies and governments conduct awareness programs and provide training for healthcare professionals on the latest medical technologies. This helps increase the adoption of new devices as healthcare providers become more knowledgeable about the benefits and usage of blood gas & electrolyte analyzers.

However, the high cost of advanced analyzers is one of the key factors restraining the market's growth. These advanced analyzers integrate advanced technology and features that offer precise & rapid results, which are crucial for critical care. Moreover, their high cost makes them less accessible to many healthcare facilities, especially in the developing countries of Southeast Asia, where budget constraints are a significant concern. In addition to the initial purchase price, advanced analyzers require ongoing expenditures for consumables such as reagents & cartridges and regular maintenance. These recurring costs can add up, making the overall cost of ownership high. Healthcare providers may be hesitant to invest in such equipment due to the long-term financial commitment required.

Browse through Grand View Research's Medical Devices Industry Research Reports.

The global surgical drills market size was estimated at USD 1.27 billion in 2023 and is projected to grow at a CAGR of 5.5% from 2024 to 2030.

The global oral appliances market size was estimated at USD 908.7 million in 2023 and is expected to grow at a CAGR of 5.72% from 2024 to 2030.

Key Blood Gas And Electrolyte Analyzer Company Insights

Some leading players operating in the market include Abbott, Radiometer Medical ApS, Werfen, and Meizhou Cornley High-Tech Co., Ltd. Key players adopt various operating strategies to maintain their market positions. One key strategy is product innovation and differentiation. Moreover, these players emphasize innovation to derive innovation and bring new solutions to the market. The rising demand for technologically advanced products drives the competition among key players.

Scitek Global Co., Ltd., EDAN Instruments, Inc., and Erba Mannheim are some of the emerging market participants. Emerging players often develop novel products with unique features to differentiate themselves. The companies are focusing on introducing tools that can help in blood gas and electrolyte analysis to meet consumer demand, which is expected to drive competition among emerging players.

Key Blood Gas And Electrolyte Analyzer Companies:

The following are the leading companies in the blood gas and electrolyte analyzer market. These companies collectively hold the largest market share and dictate industry trends.

Abbott

Meizhou Cornley High-Tech Co., Ltd.

Radiometer Medical ApS

EDAN Instruments, Inc.

Erba Mannheim

F. Hoffmann-La Roche Ltd

Fortress Diagnostics

Werfen

LifeHealth

Medica Corporation

OPTI Medical Systems, Inc.

Sensa Core

Siemens Healthineers AG

Recent Developments

In May 2024, Radiometer partnered with Etiometry to enhance workflow and clinical decision-making in hospital and healthcare settings. This partnership involves the integration of Radiometer’s acute care diagnostics with the Etiometry platform to improve the critical care settings for blood gas analysis.

In June 2023, B&E BIO-TECHNOLOGY CO., LTD. announced the launch of an i-Check handheld blood gas electrolyte to help enhance and advance point-of-care testing capabilities.

In September 2021, Sensa Core Medical Instrumentation announced the launch of ST-200CC Blood Gas Analyzers, its flagship blood gas analyzer used in clinics, hospitals, and diagnostic centers through its widespread network in India.

Order a free sample PDF of the Blood Gas And Electrolyte Analyzer Market Study, published by Grand View Research.

0 notes

shubhampawrainfinium · 5 months ago

Text

"AI-Enabled Imaging: Enhancing Precision or Just Expanding Surveillance?"

This market's growth is driven by increasing awareness of the early detection of chronic diseases, improved clinical decision-making and accuracy through AI, a shortage of healthcare professionals, advancements in AI technology, and rising regulatory approvals for AI-enabled devices. Additionally, the expanding therapeutic applications of AI-enabled devices contribute to market growth.

Market Lifecycle Stage

The AI-enabled medical imaging solutions market is currently in its development phase. Opportunities within this market are being fueled by the increasing adoption of AI and deep learning in imaging systems, technological advancements in imaging devices, and the growing use of AI-enabled medical imaging solutions in emerging markets. Key market trends include numerous collaborations among industry players, the adoption of machine learning and deep learning technologies in medical imaging, the introduction of new products, and the expansion of companies into the global market.

Impact of COVID-19

The COVID-19 pandemic initially shifted the focus of healthcare systems towards managing the crisis, leading to reduced hospital budgets and slower growth for AI applications. However, AI has been increasingly deployed in radiology departments worldwide to combat COVID-19. AI-based tools played a crucial role in diagnosis, prognosis evaluation, pandemic prediction, and drug discovery related to COVID-19, as highlighted in a September 2021 study published in Frontiers titled "Artificial Intelligence for COVID-19: A Systematic Review." This led to a positive impact on the adoption of AI in clinical settings and decision-making processes during the pandemic.

Sample pages of Report: https://www.infiniumglobalresearch.com/form/919?name=Sample

Market Segmentation

By Modality:

Computed Tomography (CT)

Magnetic Resonance (MR)

X-Ray

Ultrasound

Mammography

Multimodality Imaging Systems

Other Modalities

The CT segment is expected to dominate the global AI-enabled medical imaging solutions market.

By Product:

Software

Hardware

The software segment holds the largest share in the global AI-enabled medical imaging solutions market.

By Deployment Model:

Cloud- and Web-Based Solutions

On-Premises Solutions

Cloud- and web-based solutions dominate the global market in this category.

By Workflow:

Image Acquisition

Image Analysis

Detection

Diagnosis and Treatment Decision Support

Predictive Analysis and Risk Assessment

Triage

Reporting and Communication

The image analysis segment is expected to lead the market based on workflow.

By Therapeutic Application:

Specialty Imaging

General Imaging

Specialty imaging is anticipated to dominate the global market.

By Region:

North America: U.S., Canada

Europe: Germany, France, U.K., Italy, Spain, Switzerland, Sweden, Netherlands, and Rest-of-Europe

Asia-Pacific: Japan, China, India, Australia and New Zealand, South Korea, Singapore, and Rest-of-Asia-Pacific

Rest-of-the-World: Israel, Brazil, Mexico, and Rest-of-the-World

North America is the leading region in the global AI-enabled medical imaging solutions market.

Recent Developments in the Global AI-Enabled Medical Imaging Solutions Market

November 2022: Aidoc received U.S. FDA approval for its CT-based AI solution for diagnosing aortic dissection (AD) and all vessel occlusions (VOs).

September 2022: Aidoc partnered with Sana Klinikum Lichtenberg, Germany's largest private hospital network, to integrate its AI solution for pulmonary embolism (PE) across all facilities.

June 2022: Blackford Analysis Limited partnered with Us2.ai to bring advanced echocardiography analysis tools to the Blackford Platform.

May 2022: Butterfly Network, Inc. partnered with the Medical University of South Carolina to work on transforming patient care, health education, and medical research.

August 2021: Blackford Analysis Limited partnered with Qlarity Imaging to bring QuantX Diagnostic AI to radiologists via the Blackford Platform.

September 2021: Aidoc and Subtle Medical partnered to establish end-to-end AI solutions for medical imaging.

December 2020: Agfa HealthCare launched RUBEE for AI, a product that helps hospitals integrate AI into their imaging networks.

May 2020: Agfa HealthCare partnered with Northwest Clinics to expand the imaging platform of clinics with RUBEE for AI.

November 2021: Butterfly Network, Inc. formed a distribution partnership with Abdul Latif Jameel Health to distribute its Butterfly iQ+ ultrasound device across the Middle East, North Africa, Turkey, and India.

August 2021: Caption Health partnered exclusively with Butterfly Network Inc. to enhance early disease detection and management with AI-based diagnostics.

Report Overview : https://www.infiniumglobalresearch.com/market-reports/global-ai-enabled-imaging-solutions-market

How This Report Adds Value to an Organization

Product/Innovation Strategy: The report provides a comprehensive understanding of the various AI-enabled medical imaging solutions available for hospitals and diagnostic centers. It covers different modalities (CT, MR, X-ray, ultrasound, mammography, multimodality imaging systems, and other modalities), products (software and hardware), deployment models (cloud- and web-based solutions and on-premises solutions), workflows (image acquisition, image analysis, detection, diagnosis and treatment decision support, predictive analysis and risk assessment, triage, and reporting and communication), and therapeutic applications (specialty imaging and general imaging).

Growth/Marketing Strategy: The global AI-enabled medical imaging solutions market has witnessed significant developments, including business expansions, partnerships, collaborations, mergers and acquisitions, product launches, and funding activities. Partnerships, alliances, and business expansions make up the majority of developments in this market, followed by regulatory and legal activities and new product offerings.

Competitive Strategy: Key players in the global AI-enabled medical imaging solutions market are analyzed and profiled, with a detailed product benchmarking based on workflow, modality, and therapeutic application. This helps the reader understand how players compare against each other, presenting a clear market landscape. Additionally, the report provides insights into competitive strategies such as partnerships, agreements, collaborations, product launches and approvals, and funding scenarios, aiding in the identification of untapped revenue opportunities within the market.

0 notes

96thdayofrage · 4 years ago

Text

“Special thanks to BitDefender for helping fix our issues,” DarkSide said. “This will make us even better.”

DarkSide soon proved it wasn’t bluffing, unleashing a string of attacks. This month, it paralyzed the Colonial Pipeline Co., prompting a shutdown of the 5,500 mile pipeline that carries 45% of the fuel used on the East Coast, quickly followed by a rise in gasoline prices, panic buying of gas across the Southeast and closures of thousands of gas stations. Absent Bitdefender’s announcement, it’s possible that the crisis might have been contained, and that Colonial might have quietly restored its system with Wosar and Gillespie’s decryption tool.

Instead, Colonial paid DarkSide $4.4 million in Bitcoin for a key to unlock its files. “I will admit that I wasn’t comfortable seeing money go out the door to people like this,” CEO Joseph Blount told The Wall Street Journal.

The missed opportunity was part of a broader pattern of botched or half-hearted responses to the growing menace of ransomware, which during the pandemic has disabled businesses, schools, hospitals and government agencies across the country. The incident also shows how antivirus companies eager to make a name for themselves sometimes violate one of the cardinal rules of the cat-and-mouse game of cyber-warfare: Don’t let your opponents know what you’ve figured out. During World War II, when the British secret service learned from decrypted communications that the Gestapo was planning to abduct and murder a valuable double agent, Johnny Jebsen, his handler wasn’t allowed to warn him for fear of cluing in the enemy that its cipher had been cracked. Today, ransomware hunters like Wosar and Gillespie try to prolong the attackers’ ignorance, even at the cost of contacting fewer victims. Sooner or later, as payments drop off, the cybercriminals realize that something has gone wrong.

Whether to tout a decryption tool is a “calculated decision,” said Rob McLeod, senior director of the threat response unit for cybersecurity firm eSentire. From the marketing perspective, “You are singing that song from the rooftops about how you have come up with a security solution that will decrypt a victim’s data. And then the security researcher angle says, ‘Don’t disclose any information here. Keep the ransomware bugs that we’ve found that allow us to decode the data secret, so as not to notify the threat actors.’”

In a post on the dark web, DarkSide thanked Bitdefender for identifying a flaw in the gang’s ransomware. (Highlight added by ProPublica.)

Wosar said that publicly releasing tools, as Bitdefender did, has become riskier as ransoms have soared and the gangs have grown wealthier and more technically adept. In the early days of ransomware, when hackers froze home computers for a few hundred dollars, they often couldn’t determine how their code was broken unless the flaw was specifically pointed out to them.

Today, the creators of ransomware “have access to reverse engineers and penetration testers who are very very capable,” he said. “That’s how they gain entrance to these oftentimes highly secured networks in the first place. They download the decryptor, they disassemble it, they reverse engineer it and they figure out exactly why we were able to decrypt their files. And 24 hours later, the whole thing is fixed. Bitdefender should have known better.”

It wasn’t the first time that Bitdefender trumpeted a solution that Wosar or Gillespie had beaten it to. Gillespie had broken the code of a ransomware strain called GoGoogle and was helping victims without any fanfare, when Bitdefender released a decryption tool in May 2020. Other companies have also announced breakthroughs publicly, Wosar and Gillespie said.

“People are desperate for a news mention, and big security companies don’t care about victims,” Wosar said.

Bogdan Botezatu, director of threat research at Bucharest, Romania-based Bitdefender, said the company wasn’t aware of the earlier success in unlocking files infected by DarkSide. Regardless, he said, Bitdefender decided to publish its tool “because most victims who fall for ransomware do not have the right connection with ransomware support groups and won’t know where to ask for help unless they can learn about the existence of tools from media reports or with a simple search.”

Bitdefender has provided free technical support to more than a dozen DarkSide victims, and ��we believe many others have successfully used the tool without our intervention,” Botezatu said. Over the years, Bitdefender has helped individuals and businesses avoid paying more than $100 million in ransom, he said.

Bitdefender recognized that DarkSide might correct the flaw, Botezatu said. “We are well aware that attackers are agile and adapt to our decryptors.” But DarkSide might have “spotted the issue” anyway. “We don’t believe in ransomware decryptors made silently available. Attackers will learn about their existence by impersonating home users or companies in need, while the vast majority of victims will have no idea that they can get their data back for free.”

The attack on Colonial Pipeline, and the ensuing chaos at the gas pumps throughout the Southeast, appears to have spurred the federal government to be more vigilant. President Joe Biden issued an executive order to improve cybersecurity and create a blueprint for a federal response to cyberattacks. DarkSide said it was shutting down under U.S. pressure, although ransomware crews have often disbanded to avoid scrutiny and then re-formed under new names, or their members have launched or joined other groups.

“As sophisticated as they are, these guys will pop up again, and they’ll be that much smarter,” said Aaron Tantleff, a Chicago cybersecurity attorney who has consulted with 10 companies attacked by DarkSide. “They’ll come back with a vengeance.”

At least until now, private researchers and companies have often been more effective than the government in fighting ransomware. Last October, Microsoft disrupted the infrastructure of Trickbot, a network of more than 1 million infected computers that disseminated the notorious Ryuk strain of ransomware, by disabling its servers and communications. That month, ProtonMail, the Swiss-based email service, shut down 20,000 Ryuk-related accounts.

Wosar and Gillespie, who belong to a worldwide volunteer group called the Ransomware Hunting Team, have cracked more than 300 major ransomware strains and variants, saving an estimated 4 million victims from paying billions of dollars.

By contrast, the FBI rarely decrypts ransomware or arrests the attackers, who are typically based in countries like Russia or Iran that lack extradition agreements with the U.S. DarkSide, for instance, is believed to operate out of Russia. Far more victims seek help from the Hunting Team, through websites maintained by its members, than from the FBI.

The U.S. Secret Service also investigates ransomware, which falls under its purview of combating financial crimes. But, especially in election years, it sometimes rotates agents off cyber assignments to carry out its better-known mission of protecting presidents, vice presidents, major party candidates and their families. European law enforcement, especially the Dutch National Police, has been more successful than the U.S. in arresting attackers and seizing servers.

Similarly, the U.S. government has made only modest headway in pushing private industry, including pipeline companies, to strengthen cybersecurity defenses. Cybersecurity oversight is divided among an alphabet soup of agencies, hampering coordination. The Department of Homeland Security conducts “vulnerability assessments” for critical infrastructure, which includes pipelines.

It reviewed Colonial Pipeline in around 2013 as part of a study of places where a cyberattack might cause a catastrophe. The pipeline was deemed resilient, meaning that it could recover quickly, according to a former DHS official. The department did not respond to questions about any subsequent reviews.

Five years later, DHS created a pipeline cybersecurity initiative to identify weaknesses in pipeline computer systems and recommend strategies to address them. Participation is voluntary, and a person familiar with the initiative said that it is more useful for smaller companies with limited in-house IT expertise than for big ones like Colonial. The National Risk Management Center, which oversees the initiative, also grapples with other thorny issues such as election security.

Ransomware has skyrocketed since 2012, when the advent of Bitcoin made it hard to track or block payments. The criminals’ tactics have evolved from indiscriminate “spray and pray” campaigns seeking a few hundred dollars apiece to targeting specific businesses, government agencies and nonprofit groups with multimillion-dollar demands.

Attacks on energy businesses in particular have increased during the pandemic — not just in the U.S. but in Canada, Latin America and Europe. As the companies allowed employees to work from home, they relaxed some security controls, McLeod said.

Since 2019, numerous gangs have ratcheted up pressure with a technique known as “double extortion.” Upon entering a system, they steal sensitive data before launching ransomware that encodes the files and makes it impossible for hospitals, universities and cities to do their daily work. If the loss of computer access is not sufficiently intimidating, they threaten to reveal confidential information, often posting samples as leverage. For instance, when the Washington, D.C., police department didn’t pay the $4 million ransom demanded by a gang called Babuk last month, Babuk published intelligence briefings, names of criminal suspects and witnesses, and personnel files, from medical information to polygraph test results, of officers and job candidates.

DarkSide, which emerged last August, epitomized this new breed. It chose targets based on a careful financial analysis or information gleaned from corporate emails. For instance, it attacked one of Tantleff’s clients during a week when the hackers knew the company would be vulnerable because it was transitioning its files to the cloud and didn’t have clean backups.

To infiltrate target networks, the gang used advanced methods such as “zero-day exploits” that immediately take advantage of software vulnerabilities before they can be patched. Once inside, it moved swiftly, looking not only for sensitive data but also for the victim’s cyber insurance policy, so it could peg its demands to the amount of coverage. After two to three days of poking around, DarkSide encrypted the files.

“They have a faster attack window,” said Christopher Ballod, associate managing director for cyber risk at Kroll, the business investigations firm, who has advised half a dozen DarkSide victims. “The longer you dwell in the system, the more likely you are to be caught.”

Typically, DarkSide’s demands were “on the high end of the scale,” $5 million and up, Ballod said. One scary tactic: If publicly traded companies didn’t pay the ransom, DarkSide threatened to share information stolen from them with short-sellers who would profit if the share price dropped upon publication.

DarkSide’s site on the dark web identified dozens of victims and described the confidential data it claimed to have filched from them. One was New Orleans law firm Stone Pigman Walther Wittmann. “A big annoyance is what it was,” attorney Phil Wittmann said, referring to the DarkSide attack in February. “We paid them nothing,” said Michael Walshe Jr., chair of the firm’s management committee, declining to comment further.

Last November, DarkSide adopted what is known as a “ransomware-as-a-service” model. Under this model, it partnered with affiliates who launched the attacks. The affiliates received 75% to 90% of the ransom, with DarkSide keeping the remainder. As this partnership suggests, the ransomware ecosystem is a distorted mirror of corporate culture, with everything from job interviews to procedures for handling disputes. After DarkSide shut down, several people who identified themselves as its affiliates complained on a dispute resolution forum that it had stiffed them. “The target paid, but I did not receive my share,” one wrote.

Together, DarkSide and its affiliates reportedly grossed at least $90 million. Seven of Tantleff’s clients, including two companies in the energy industry, paid ransoms ranging from $1.25 million to $6 million, reflecting negotiated discounts from initial demands of $7.5 million to $30 million. His other three clients hit by DarkSide did not pay. In one of those cases, the hackers demanded $50 million. Negotiations grew acrimonious, and the two sides couldn’t agree on a price.

DarkSide’s representatives were shrewd bargainers, Tantleff said. If a victim said it couldn’t afford the ransom because of the pandemic, DarkSide was ready with data showing that the company’s revenue was up, or that COVID-19’s impact was factored into the price.

DarkSide’s grasp of geopolitics was less advanced than its approach to ransomware. Around the same time that it adopted the affiliate model, it posted that it was planning to safeguard information stolen from victims by storing it in servers in Iran. DarkSide apparently didn’t realize that an Iranian connection would complicate its collection of ransoms from victims in the U.S., which has economic sanctions restricting financial transactions with Iran. Although DarkSide later walked back this statement, saying that it had only considered Iran as a possible location, numerous cyber insurers had concerns about covering payments to the group. Coveware, a Connecticut firm that negotiates with attackers on behalf of victims, stopped dealing with DarkSide.

Ballod said that, with their insurers unwilling to reimburse the ransom, none of his clients paid DarkSide, despite concerns about exposure of their data. Even if they had caved in to DarkSide, and received assurances from the hackers in return that the data would be shredded, the information might still leak, he said.

During DarkSide’s changeover to the affiliate model, a flaw was introduced into its ransomware. The vulnerability caught the attention of members of the Ransomware Hunting Team. Established in 2016, the invitation-only team consists of about a dozen volunteers in the U.S., Spain, Italy, Germany, Hungary and the U.K. They work in cybersecurity or related fields. In their spare time, they collaborate in finding and decrypting new ransomware strains.

Several members, including Wosar, have little formal education but an aptitude for coding. A high school dropout, Wosar grew up in a working-class family near the German port city of Rostock. In 1992, at the age of 8, he saw a computer for the first time and was entranced. By 16, he was developing his own antivirus software and making money from it. Now 37, he has worked for antivirus firm Emsisoft since its inception almost two decades ago and is its chief technology officer. He moved to the U.K. from Germany in 2018 and lives near London.

He has been battling ransomware hackers since 2012, when he cracked a strain called ACCDFISA, which stood for “Anti Cyber Crime Department of Federal Internet Security Agency.” This fictional agency was notifying people that child pornography had infected their computers, and so it was blocking access to their files unless they paid $100 to remove the virus.

The ACCDFISA hacker eventually noticed that the strain had been decrypted and released a revised version. Many of Wosar’s subsequent triumphs were also fleeting. He and his teammates tried to keep criminals blissfully unaware for as long as possible that their strain was vulnerable. They left cryptic messages on forums inviting victims to contact them for assistance or sent direct messages to people who posted that they had been attacked.

In the course of protecting against computer intrusions, analysts at antivirus firms sometimes detected ransomware flaws and built decryption tools, though it wasn’t their main focus. Sometimes they collided with Wosar.

In 2014, Wosar discovered that a ransomware strain called CryptoDefense copied and pasted from Microsoft Windows some of the code it used to lock and unlock files, not realizing that the same code was preserved in a folder on the victim’s own computer. It was missing the signal, or “flag,” in their program, usually included by ransomware creators to instruct Windows not to save a copy of the key.

Wosar quickly developed a decryption tool to retrieve the key. “We faced an interesting conundrum,” Sarah White, another Hunting Team member, wrote on Emsisoft’s blog. “How to get our tool out to the most victims possible without alerting the malware developer of his mistake?”

Wosar discreetly sought out CryptoDefense victims through support forums, volunteer networks and announcements of where to contact for help. He avoided describing how the tool worked or the blunder it exploited. When victims came forward, he supplied the fix, scrubbing the ransomware from at least 350 computers. CryptoDefense eventually “caught on to us ... but he still did not have access to the decrypter we used and had no idea how we were unlocking his victims’ files,” White wrote.

But then an antivirus company, Symantec, uncovered the same problem and bragged about the discovery on a blog post that “contained enough information to help the CryptoDefense developer find and correct the flaw,” White wrote. Within 24 hours the attackers began spreading a revised version. They changed its name to CryptoWall and made $325 million.

Symantec “chose quick publicity over helping CryptoDefense victims recover their files,” White wrote. “Sometimes there are things that are better left unsaid.”

A spokeswoman for Broadcom, which acquired Symantec’s enterprise security business in 2019, declined to comment, saying that “the team members who worked on the tool are no longer with the company.”

Like Wosar, the 29-year-old Gillespie comes from poverty and never went to college. When he was growing up in central Illinois, his family struggled so much financially that they sometimes had to move in with friends or relatives. After high school, he worked full time for 10 years at a computer repair chain called Nerds on Call. Last year, he became a malware and cybersecurity researcher at Coveware.

Last December, he messaged Wosar for help. Gillespie had been working with a DarkSide victim who had paid a ransom and received a tool to recover the data. But DarkSide’s decryptor had a reputation for being slow, and the victim hoped that Gillespie could speed up the process.

Gillespie analyzed the software, which contained a key to release the files. He wanted to extract the key, but because it was stored in an unusually complex way, he couldn’t. He turned to Wosar, who was able to isolate it.

The teammates then began testing the key on other files infected by DarkSide. Gillespie checked files uploaded by victims to the website he operates, ID Ransomware, while Wosar used VirusTotal, an online database of suspected malware.

That night, they shared a discovery.

“I have confirmation DarkSide is re-using their RSA keys,” Gillespie wrote to the Hunting Team on its Slack channel. A type of cryptography, RSA generates two keys: a public key to encode data and a private key to decipher it. RSA is used legitimately to safeguard many aspects of e-commerce, such as protecting credit numbers. But it’s also been co-opted by ransomware hackers.

“I noticed the same as I was able to decrypt newly encrypted files using their decrypter,” Wosar replied less than an hour later, at 2:45 a.m. London time.

Their analysis showed that, before adopting the affiliate model, DarkSide had used a different public and private key for each victim. Wosar suspected that, during this transition, DarkSide introduced a mistake into its affiliate portal used to generate the ransomware for each target. Wosar and Gillespie could now use the key that Wosar had extracted to retrieve files from Windows machines seized by DarkSide. The cryptographic blunder didn’t affect Linux operating systems.

“We were scratching our heads,” Wosar said. “Could they really have fucked up this badly? DarkSide was one of the more professional ransomware-as-a-service schemes out there. For them to make such a huge mistake is very, very rare.”

The Hunting Team celebrated quietly, without seeking publicity. White, who is a computer science student at Royal Holloway, part of the University of London, began looking for DarkSide victims. She contacted firms that handle digital forensics and incident response.

“We told them, ‘Hey listen, if you have any DarkSide victims, tell them to reach out to us, we can help them. We can recover their files and they don’t have to pay a huge ransom,’” Wosar said.

The DarkSide hackers mostly took the Christmas season off. Gillespie and Wosar expected that, when the attacks resumed in the new year, their discovery would help dozens of victims. But then Bitdefender published its post, under the headline “Darkside Ransomware Decryption Tool.”

In a messaging channel with the ransomware response community, someone asked why Bitdefender would tip off the hackers. “Publicity,” White responded. “Looks good. I can guarantee they’ll fix it much faster now though.”

She was right. The next day, DarkSide acknowledged the error that Wosar and Gillespie had found before Bitdefender. “Due to the problem with key generation, some companies have the same keys,” the hackers wrote, adding that up to 40% of keys were affected.

DarkSide mocked Bitdefender for releasing the decryptor at “the wrong time…., as the activity of us and our partners during the New Year holidays is the lowest.”

Adding to the team’s frustrations, Wosar discovered that the Bitdefender tool had its own drawbacks. Using the company’s decryptor, he tried to unlock samples infected by DarkSide and found that they were damaged in the process. “They actually implemented the decryption wrong,” Wosar said. “That means if victims did use the Bitdefender tool, there’s a good chance that they damaged the data.”

Asked about Wosar’s criticism, Botezatu said that data recovery is difficult, and that Bitdefender has “taken all precautions to make sure that we’re not compromising user data” including exhaustive testing and “code that evaluates whether the resulting decrypted file is valid.”

Even without Bitdefender, DarkSide might have soon realized its mistake anyway, Wosar and Gillespie said. For example, as they sifted through compromised networks, the hackers might have come across emails in which victims helped by the Hunting Team discussed the flaw.

“They might figure it out that way — that is always a possibility,” Wosar said. “But it’s especially painful if a vulnerability is being burned through something stupid like this.”

The incident led the Hunting Team to coin a term for the premature exposure of a weakness in a ransomware strain. “Internally, we often joke, ‘Yeah, they are probably going to pull a Bitdefender,’” Wosar said.

1 note · View note